Skip to main content
Premium Trial:

Request an Annual Quote

Orchid Posts Decline in Q3 Service Revenue as Total Receipts Remain Flat and Losses Surge

Click here for an updated version of this article.

NEW YORK, Oct. 27 (GenomeWeb News) - Orchid Cellmark today reported flat third-quarter revenues amid declining R&D spending and surging net losses.

 

Total receipts for the three months ended Sept. 30 were flat at $16.4 million, the company said. Revenue from services declined to $16.3 million from $16.4 million in the year-ago period. Other revenue increased to $156,000 from $93,000 year over year.

 

Orchid CEO Paul Kelly said he was "disappointed" by the performance of the USforensic business, but said he was "encouraged" with growth in other areas of the business.

 

During the quarter, he said, the company "experienced a slowdown in forensic casework production from implementation of new software and processes designed to further automate our casework sample analyses." He called this development "temporary" and said the company is "addressing" it as it wraps up implementing the new processes and hiring additional DNA analysts.

 

Kelly also said "there are many positive developments" that support growth in the US forensic DNA testing market, including "major legislative initiatives in support of increased forensic DNA testing, enhanced use of DNA by law enforcement to solve more crimes such as burglary, and Congressional approval of significantly expanded federal funding."

 

He added: "While we are frustrated by the continued bureaucratic delays in the award of NIJ funds by the states and localities, we believe Orchid Cellmark's potential for continued strong growth in its U.S.forensic DNA testing business remains unchanged."

 

Orchid said R&D spending for the third quarter declined to $376,000 from $426,000 year over year.

 

Net losses surged to $3.8 million, or $.15 per basic share, from $395,000, or $.02 per basic share, in the same period last year.

 

Orchid said it had around $18.4 million in cash and equivalents and $6 million in short-term investments as of Sept. 30.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.